ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis

BACKGROUND: We sought to assess the relative effects of individual anaplastic lymphoma kinase (ALK) inhibitors for the treatment of non-small cell lung cancer (NSCLC). METHODS: We searched MEDLINE, Embase, Cochrane CENTRAL, and grey literature (July 23, 2019) for randomized controlled trials (RCTs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Jesse, Bai, Zemin, Hsieh, Shu-Ching, Kelly, Shannon E., Chen, Li, Skidmore, Becky, Yousef, Said, Zheng, Carine, Stewart, David J., Wells, George A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029857/
https://www.ncbi.nlm.nih.gov/pubmed/32074131
http://dx.doi.org/10.1371/journal.pone.0229179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029857/
https://www.ncbi.nlm.nih.gov/pubmed/32074131
http://dx.doi.org/10.1371/journal.pone.0229179

Ejemplares similares